15.06USD-3.89%Mkt Cap: 451.64M $P/E: —1d ago
ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States. Th…
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap451.64M $
Enterprise Value479.64M $
Revenue (TTM)40.61M $
Gross Profit22.69M $
Net Income (TTM)-25.54M $
Revenue/Share1.412 USD
Last Price15.06 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees172
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-16.02
PEG0.61
EV/EBITDA-20.32
EV/Revenue11.81
P/S11.12
P/B23.98
EPS (TTM)-1.00
EPS (Forward)-0.94
52W Range
8.27031% of range30.10
52W High30.10 USD
52W Low8.270 USD
Profitability
Gross Margin61.38%
Oper. Margin-69.90%
EBITDA Margin-58.12%
Profit Margin-69.08%
ROE-91.15%
ROA-26.13%
Growth
Revenue Growth42.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-23.93M $
CapEx (TTM)522.00K $
FCF Margin-28.64%
FCF Yield-2.58%
Net Debt28.00M $
Net Debt/EBITDA-1.19
Balance Sheet
Debt/Equity2.08
Current Ratio5.79
Quick Ratio4.75
Book Value/Sh0.6280 USD
Cash/Share1.187 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJul 27, 2016
Splits
Last Split1:40
Split DateJul 27, 2016
Analyst Consensus
Rating—
Target (Mean)28.33 USD
Upside (mean)+88.1%
Target Range25.00 USD – 30.00 USD
$25.00+88.1% to mean$30.00
# Analysts3
Ownership
Shares Out.29.99M
Float26.27M
Insiders5.48%
Institutions50.62%
Short Interest
Short Ratio4.1d
Short % Float14.84%
Short % Out.14.34%
Shares Short4.30M
Short (prev mo.)4.74M
Technical
SMA 5014.41 (+4.5%)
SMA 20014.85 (+1.4%)
Beta1.24
S&P 52W Chg20.25%
Avg Vol (30d)854.28K
Avg Vol (10d)470.06K
Technical Indicators
RSI (14)43.5
MACD0.4974
MACD Signal1.0322
MACD Hist.-0.5348
BB Upper20.23 USD
BB Middle17.34 USD
BB Lower14.44 USD
BB Width33.41%
ATR (14)1.188 USD
Vol Ratio (20d)0.58x